RetroSense Therapeutics Raises $6M Series B
RetroSense Therapeutics a biotechnology company raises $6M in a Series B financing. RetroSense Therapeutics is a biotechnology company that is developing a game-changing gene therapy to restore vision in patients suffering from blindness due to retinitis pigmentosa (RP) and advanced…